New Key Statistics Module, Z-Score and F-Score
NSE:ORISSAMINE Key Ratios
| Market Cap ₹ M | 34,246.50 |
| Enterprise Value ₹ M | 36,005.64 |
| P/E(ttm) | 793.72 |
| PE Ratio without NRI | 854.90 |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 66.80 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ₹ M | 518.00 |
| EPS (TTM) ₹ | 7.28 |
| Beneish M-Score | -1.94 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -23.90 |
| EV-to-EBIT | 454.16 |
| EV-to-EBITDA | 454.16 |
| PEG | -- |
| Shares Outstanding M | 6.00 |
| Net Margin (%) | 8.42 |
| Operating Margin % | 7.46 |
| Pre-tax Margin (%) | -22.51 |
| Quick Ratio | 0.27 |
| Current Ratio | 0.32 |
| ROA % (ttm) | 1.12 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -0.23 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.48 |
NSE:ORISSAMINE Number of Guru Trades
NSE:ORISSAMINE Volume of Guru Trades
Gurus Latest Trades with NSE:ORISSAMINE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:ORISSAMINE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers